Dr. David B. Kovacs is a rheumatologist in Mission Viejo,California. He graduated from Medical College of Wisconsin in 2007 and has been in practice for 15 years.
Male
1861633083
Description | # of Times Performed | # of Patients | Average Charge ($) |
---|---|---|---|
Aspiration and/or injection of large joint or joint capsule | 108.0 | 64.0 | 226.72222222 |
Insertion of needle into vein for collection of blood sample | 106.0 | 66.0 | 13.0 |
Blood test, comprehensive group of blood chemicals | 94.0 | 50.0 | 32.0 |
Complete blood cell count (red cells, white blood cell, platelets), automated test | 87.0 | 50.0 | 43.0 |
Red blood cell sedimentation rate, to detect inflammation | 105.0 | 62.0 | 29.0 |
Measurement C-reactive protein for detection of infection or inflammation | 57.0 | 29.0 | 24.0 |
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 148.0 | 37.0 | 169.0 |
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 177.0 | 38.0 | 50.0 |
Infusion of chemotherapy into a vein up to 1 hour | 62.0 | 25.0 | 424.0 |
Infusion of chemotherapy into a vein | 85.0 | 25.0 | 114.0 |
New patient office or other outpatient visit, typically 45 minutes | 95.0 | 95.0 | 291.48421053 |
Established patient office or other outpatient, visit typically 25 minutes | 845.0 | 334.0 | 192.80473373 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 26800.0 | 13.0 | 15.0 |
Injection, denosumab, 1 mg | 1320.0 | 15.0 | 34.0 |
Injection, methylprednisolone acetate, 20 mg | 21.0 | 13.0 | 12.0 |
Injection, methylprednisolone acetate, 40 mg | 22.0 | 14.0 | 26.0 |
Injection, methylprednisolone acetate, 80 mg | 42.0 | 30.0 | 40.0 |
Injection, infliximab, excludes biosimilar, 10 mg | 2236.0 | 20.0 | 124.76784436 |
Injection, tocilizumab, 1 mg | 30230.0 | 13.0 | 8.8334634469 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 79.0 | 19.0 | 331.0 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.